LumiraDx Past Earnings Performance
Past criteria checks 0/6
LumiraDx's earnings have been declining at an average annual rate of -22.3%, while the Medical Equipment industry saw earnings growing at 11.1% annually. Revenues have been growing at an average rate of 18.4% per year.
Key information
-22.3%
Earnings growth rate
10.7%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | 18.4% |
| Return on equity | n/a |
| Net Margin | -267.2% |
| Last Earnings Update | 30 Jun 2023 |
Recent past performance updates
Recent updates
Market Cool On LumiraDx Limited's (NASDAQ:LMDX) Revenues Pushing Shares 27% Lower
Dec 20
LumiraDx Limited's (NASDAQ:LMDX) Revenues Are Not Doing Enough For Some Investors
Apr 17What You Need To Know About The LumiraDx Limited (NASDAQ:LMDX) Analyst Downgrade Today
Nov 16Need To Know: The Consensus Just Cut Its LumiraDx Limited (NASDAQ:LMDX) Estimates For 2022
Aug 20LumiraDx GAAP EPS of -$0.58, revenue of $44.7M
Aug 18Bill & Melinda Gates Foundation discloses 7.4% passive stake in LumiraDx
Jul 15Revenue & Expenses BreakdownBeta
How LumiraDx makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 23 | 127 | -338 | 114 | 87 |
| 31 Mar 23 | 150 | -436 | 129 | 118 |
| 31 Dec 22 | 254 | -448 | 143 | 140 |
| 30 Sep 22 | 332 | -384 | 151 | 154 |
| 30 Jun 22 | 398 | -108 | 144 | 158 |
| 31 Mar 22 | 441 | 24 | 133 | 145 |
| 31 Dec 21 | 421 | -101 | 131 | 130 |
| 30 Sep 21 | 415 | -183 | 109 | 124 |
| 30 Jun 21 | 320 | -331 | 93 | 117 |
| 31 Mar 21 | 240 | -368 | 75 | 108 |
| 31 Dec 20 | 139 | -241 | 46 | 108 |
| 30 Sep 20 | 33 | -201 | 41 | 103 |
| 30 Jun 20 | 25 | -171 | 39 | 98 |
| 31 Mar 20 | 24 | -152 | 38 | 92 |
| 31 Dec 19 | 23 | -133 | 37 | 87 |
| 31 Dec 18 | 25 | -115 | 36 | 67 |
Quality Earnings: LMDX.F is currently unprofitable.
Growing Profit Margin: LMDX.F is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: LMDX.F is unprofitable, and losses have increased over the past 5 years at a rate of 22.3% per year.
Accelerating Growth: Unable to compare LMDX.F's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: LMDX.F is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (2.6%).
Return on Equity
High ROE: LMDX.F's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.